Summary
- Current Price
- As of today, CRL price is $164.24, up +3.95% on
- Current Price All-Time High
- CRL price is currently -64.31% below its historical high of $460.21 set on
- Market Cap
- CRL current market cap is $8B, down -4.21% year-over-year
- PE Ratio
- CRL PE ratio is unknown
- Revenue
- CRL current annual revenue is $4.05B, down -1.92% year-over-year
- Next Earnings
- As of today, the next earnings release for CRL has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Charles River Laboratories International, Inc. |
| Ticker | NYSE: CRL |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | criver.com |
| Employees | 18,700 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $164.24 | |
| Price, 1D Change | +3.95% | |
| Market Cap | $8B | |
| - | ||
| PE Ratio | - | |
| Beta | 1.44 | |
| Revenue | $4B | |
| Revenue, 1Y Change | -1.92% | |
| EPS | $0.20 | |
| EPS, 1Y Change | -97.84% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.20 | |
| EPS Estimate | N/A | $10.24 |
| EPS Est. Change | N/A | +5,035.56% |
| Revenue | $4.05B | |
| Revenue Estimate | N/A | $4.01B |
| Revenue Est. Change | N/A | -1.09% |
| Current Price | $164.24 | |
| Price Target | - | $215.00 |
| Price Tgt. Change | - | +30.91% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $10.59 | $9.22 | -12.89% | |
| $10.18 | $0.20 | -98.04% | |
| $10.24 | N/A | +5,035.56% | |
| $10.95 | N/A | +5,393.18% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.10B | $4.13B | +0.63% | |
| $4.03B | $4.05B | +0.47% | |
| $4.01B | N/A | -1.09% | |
| $4.07B | N/A | +0.60% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -0.46% | |
| Price, 3Y | -34.24% | |
| Market Cap, 1Y | -4.21% | |
| Market Cap, 3Y | -36.52% | |
| Revenue, 1Y | -1.92% | |
| Revenue, 3Y | +14.40% | |
| EPS, 1Y | -97.84% | |
| EPS, 3Y | -97.38% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $164.24 | |
| SMA 200 | $169.92 | |
| SMA 200 vs Price | +3.46% | |
| SMA 50 | $200.47 | |
| SMA 50 vs Price | +22.06% | |
| Beta | 1.44 | |
| ATR | $9.60 | |
| 14-Day RSI | 31.26 | |
| 10-Day Volatility | 69.95% | |
| 1-Year Volatility | 55.25% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $4.05B | |
| EPS | $0.20 | |
| Gross Profit | $1.27B | |
| Gross Margin | 31.35% | |
| Operating Profit | $566.88M | |
| Operating Margin | -54.66% | |
| Net Income | $25.29M | |
| Net Margin | 0.62% | |
| EBITDA | $928.62M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.80 | |
| 1.41 | ||
| 1.13 | ||
| - | ||
| 5 | ||
| 2.39 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| 2.01 | ||
| 2.37 | ||
| 11.58 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $3.46B | |
| $204.14M | ||
| $7.53B | ||
| $1.40B | ||
| $4.02B | ||
| $994.10M | ||
| Total Debt | $2.78B | |
| $57.09M | ||
| $140.34M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $4.04B | ||
| $702.60M | ||
| $2.78B | ||
| $0.00 | ||
| $361.74M | ||
| $0.00 | ||
| $67.82M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $734.58M | ||
| -$245.09M | ||
| -$550.93M | ||
| Capex | $232.97M | |
| $501.61M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Citigroup | → | |
| Evercore ISI Group | → | |
| Mizuho | → | |
| JP Morgan | → | |
| Barclays | → | |
| Morgan Stanley | → | |
| TD Cowen | → | |
| JP Morgan | → | |
| Barclays | → | |
| Baird | → |
Analyst sentiment
Institutional ownership
Screeners with CRL
FAQ
What is the ticker symbol for Charles River Laboratories International, Inc.?
The ticker symbol for Charles River Laboratories International, Inc. is NYSE:CRL
Does Charles River Laboratories International, Inc. pay dividends?
No, Charles River Laboratories International, Inc. does not pay dividends
What sector is Charles River Laboratories International, Inc. in?
Charles River Laboratories International, Inc. is in the Healthcare sector
What industry is Charles River Laboratories International, Inc. in?
Charles River Laboratories International, Inc. is in the Diagnostics & Research industry
What country is Charles River Laboratories International, Inc. based in?
Charles River Laboratories International, Inc. is headquartered in United States
When did Charles River Laboratories International, Inc. go public?
Charles River Laboratories International, Inc. initial public offering (IPO) was on June 23, 2000
Is Charles River Laboratories International, Inc. in the S&P 500?
Yes, Charles River Laboratories International, Inc. is included in the S&P 500 index
Is Charles River Laboratories International, Inc. in the NASDAQ 100?
No, Charles River Laboratories International, Inc. is not included in the NASDAQ 100 index
Is Charles River Laboratories International, Inc. in the Dow Jones?
No, Charles River Laboratories International, Inc. is not included in the Dow Jones index
When was Charles River Laboratories International, Inc. last earnings report?
Charles River Laboratories International, Inc.'s most recent earnings report was on February 18, 2026
When does Charles River Laboratories International, Inc. report earnings?
The date for Charles River Laboratories International, Inc.'s next earnings report has not been announced yet
Data Sources & References
- CRL Official Website www.criver.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1100682/000110068225000043/0001100682-25-000043-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1100682/000110068225000011/0001100682-25-000011-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- CRL Profile on Yahoo Finance finance.yahoo.com/quote/CRL
- CRL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/crl